A new monocyte chemotactic protein-1/chemokine CC motif ligand-2 competitor limiting neointima formation and myocardial ischemia/reperfusion injury in mice.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of the American College of Cardiology

• Publication date

  2010-11-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jacc.2010.04.066PMID 21087715
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rationally Evolving MCP-1/CCL2 into a Decoy Protein with Potent Anti-inflammatory Activity in Vivo*

  2010cited by this paper
• Therapeutic targeting of chemokine interactions in atherosclerosis

  2010cited by this paper
• Regulated release and functional modulation of junctional adhesion molecule A by disintegrin metalloproteinases.

  2009cited by this paper
• Therapeutically targeting protein–glycan interactions

  2009cited by this paper
• Engineering the glycosaminoglycan-binding affinity, kinetics and oligomerization behavior of RANTES: a tool for generating chemokine-based glycosaminoglycan antagonists.

  2009cited by this paper
• Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice

  2009cited by this paper
• Chemokine receptor antagonists: overcoming developmental hurdles

  2009cited by this paper
• The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models

  2008cited by this paper
• An engineered monomer of CCL2 has anti‐inflammatory properties emphasizing the importance of oligomerization for chemokine activity in vivo

  2008cited by this paper
• Angiotensin-receptor blockade reduces border zone myocardial monocyte chemoattractant protein-1 expression and macrophage infiltration in post-infarction ventricular remodeling.

  2008cited by this paper
• Pharmacological Profile of JNJ-27141491 [(S)-3-[3,4-Difluorophenyl)-propyl]-5-isoxazol-5-yl-2-thioxo-2,3-dihydro-1H-imidazole-4-carboxyl Acid Methyl Ester], as a Noncompetitive and Orally Active Antagonist of the Human Chemokine Receptor CCR2

  2008cited by this paper
• Chemokines in Atherosclerosis , Thrombosis , and Vascular Biology Series Editor : Christian Weber Chemokines in Atherosclerosis An Update

  2008cited by this paper
• A Novel RANTES Antagonist Prevents Progression of Established Atherosclerotic Lesions in Mice

  2008cited by this paper
• Chemokines in ischemia and reperfusion

  2007cited by this paper
• The Novel CXCL12γ Isoform Encodes an Unstructured Cationic Domain Which Regulates Bioactivity and Interaction with Both Glycosaminoglycans and CXCR4

  2007cited by this paper
• Critical Role of Monocyte Chemoattractant Protein-1/CC Chemokine Ligand 2 in the Pathogenesis of Ischemic Cardiomyopathy

  2007cited by this paper
• Ccr1 deficiency reduces inflammatory remodelling and preserves left ventricular function after myocardial infarction

  2007cited by this paper
• MCP‐1/CCR2‐dependent loop for fibrogenesis in human peripheral CD14‐positive monocytes

  2006cited by this paper
• Monocyte Chemoattractant Protein-1 Induces a Novel Transcription Factor That Causes Cardiac Myocyte Apoptosis and Ventricular Dysfunction

  2006cited by this paper
• A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis.

  2006cited by this paper
• Developing chemokine mutants with improved proteoglycan affinity and knocked-out GPCR activity as anti-inflammatory recombinant drugs.

  2006cited by this paper
• CC chemokine receptor-2 deficiency attenuates oxidative stress and infarct size caused by myocardial ischemia-reperfusion in mice.

  2006cited by this paper
• Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-alpha/beta-induced inflammatory responses and antiviral defense in liver.

  2005cited by this paper
• Recruitment of Gr-1+ monocytes is essential for control of acute toxoplasmosis

  2005cited by this paper
• CCL2/Monocyte Chemoattractant Protein-1 Regulates Inflammatory Responses Critical to Healing Myocardial Infarcts

  2005cited by this paper
• Gene Profiling in Atherosclerosis Reveals a Key Role for Small Inducible Cytokines: Validation Using a Novel Monocyte Chemoattractant Protein Monoclonal Antibody

  2005cited by this paper
• Monocyte Chemoattractant Protein-1 and CCR2 Interactions Are Required for IFN-α/β-Induced Inflammatory Responses and Antiviral Defense in Liver1

  2005cited by this paper
• Neointimal Smooth Muscle Cells Display a Proinflammatory Phenotype Resulting in Increased Leukocyte Recruitment Mediated by P-Selectin and Chemokines

  2004cited by this paper
• Crucial Role of the CCL2/CCR2 Axis in Neointimal Hyperplasia After Arterial Injury in Hyperlipidemic Mice Involves Early Monocyte Recruitment and CCL2 Presentation on Platelets

  2004cited by this paper
• Interference with Heparin Binding and Oligomerization Creates a Novel Anti-Inflammatory Strategy Targeting the Chemokine System

  2004cited by this paper
• Molecular and cellular events at the site of myocardial infarction: from the perspective of rebuilding myocardial tissue.

  2004cited by this paper
• Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction.

  2004cited by this paper
• Blockade of Keratinocyte-Derived Chemokine Inhibits Endothelial Recovery and Enhances Plaque Formation After Arterial Injury in ApoE-Deficient Mice

  2004cited by this paper
• Inflammatory mechanisms in myocardial infarction.

  2003cited by this paper
• Anti‐monocyte chemoattractant protein‐1 gene therapy inhibits restenotic changes (neointimal hyperplasia) after balloon injury in rats and monkeys

  2002cited by this paper
• The inflammatory response in myocardial infarction.

  2002cited by this paper
• Myocardial Infarction and Cardiac Remodelling in Mice

  2002cited by this paper
• Dynamics of cardiac wound healing following myocardial infarction: observations in genetically altered mice.

  2001cited by this paper
• Examination of the Function of RANTES, MIP-1α, and MIP-1β following Interaction with Heparin-like Glycosaminoglycans*

  2000cited by this paper
• Examination of the function of RANTES, MIP-1alpha, and MIP-1beta following interaction with heparin-like glycosaminoglycans.

  2000cited by this paper
• Infarct scar: a dynamic tissue.

  2000cited by this paper
• Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2.

  1999cited by this paper
• Expression of CCR2 by endothelial cells : implications for MCP-1 mediated wound injury repair and In vivo inflammatory activation of endothelium.

  1999cited by this paper
• Monocyte chemoattractant protein-1.

  1999cited by this paper
• Extension of Recombinant Human RANTES by the Retention of the Initiating Methionine Produces a Potent Antagonist (*)

  1996cited by this paper
• Tumor necrosis factor induces enhanced responses to platelet‐activating factor and differentiation in human monocytic Mono Mac 6 cells

  1993cited by this paper

• Pharmacological and Genetic Targeting of Inflammatory Chemokine Receptors CCR1, CCR2, and CCR5 in Atherosclerosis: A Systematic Review and Meta-Analysis of Preclinical Studies.

  2026cites this paper
• Extracellular RNA Drives TNF-α/TNF-Receptor-1 mediated cardiac ischemia/reperfusion injury: Mechanistic insights and therapeutic potential of RNase1.

  2025cites this paper
• GDF11 improves cardiac repair after myocardial infarction by reducing Macrophage infiltration and attenuating their inflammatory Properties.

  2025cites this paper
• Antagonizing CCR2 With Propagermanium Leads to Altered Distribution of Macrophage Subsets and Favorable Tissue Remodeling After Myocardial Infarction in Mice

  2025cites this paper
• Preventive Administration of Quercetin Promotes Survival and Reduces Adverse Ventricular Remodeling after myocardial infarction through facilitating M2-like macrophage polarization.

  2025cites this paper
• Immune cell dynamics in heart failure: implicated mechanisms and therapeutic targets

  2025cites this paper
• CCL2-CCR2 axis in cardiovascular disease: Research advances and challenges.

  2025cites this paper
• Lymphatic Endothelial C‐C Motif Chemokine Ligand 2 Enhances Lymphangiogenesis and Lymphatic Clearance of Macrophages Following Myocardial Infarction

  2025cites this paper
• Cardiac macrophages and their functions in homeostasis and injury.

  2025cites this paper
• Emerging Role of Macrophage-Fibroblast Interactions in Cardiac Homeostasis and Remodeling

  2024cites this paper
• Mental disorders after myocardial infarction: potential mediator role for chemokines in heart-brain interaction?

  2024cites this paper
• An injectable polyacrylamide/chitosan-based hydrogel with highly adhesive, stretchable and electroconductive properties loaded with irbesartan for treatment of myocardial ischemia-reperfusion injury.

  2024cites this paper
• Macrophages in cardiovascular fibrosis: novel subpopulations, molecular mechanisms, and therapeutic targets.

  2024cites this paper
• Role of inflammation and immune response in atherosclerosis: Mechanisms, modulations, and therapeutic targets.

  2023cites this paper
• Targeting inflammation to reduce recurrent stroke

  2023cites this paper
• Application of locally responsive design of biomaterials based on microenvironmental changes in myocardial infarction

  2023cites this paper
• Preservation solution Custodiol containing human alpha-1-antitrypsin improves graft recovery after prolonged cold ischemic storage in a rat model of heart transplantation

  2023cites this paper
• CXCL16 Promotes Ly6Chigh Monocyte Infiltration and Impairs Heart Function after Acute Myocardial Infarction.

  2023cites this paper
• Macrophages in cardiac remodelling after myocardial infarction

  2023cites this paper
• Inflammatory Mediators in Atherosclerotic Vascular Remodeling

  2022cites this paper
• Macrophage Targeting for Therapy of Cardiovascular Diseases (CVD)

  2022cites this paper
• Sinapic Acid Attenuated Cardiac Remodeling After Myocardial Infarction by Promoting Macrophage M2 Polarization Through the PPARγ Pathway

  2022cites this paper
• Alterations of long noncoding RNAs and mRNAs in extracellular vesicles derived from the murine heart post‐ischemia–reperfusion injury

  2022cites this paper
• FMF Kliniğine Alternatif Bir Bakış Açısı: MCP-1 (A-2518G) ve CCR2 (G190A) Polimorfizmleri ve MCP1 Ekspresyonu

  2022cites this paper
• Macrophages in myocardial infarction.

  2022cites this paper
• Role of the CCL2-CCR2 axis in cardiovascular disease: Pathogenesis and clinical implications

  2022cites this paper
• Cytokine storm: behind the scenes of the collateral circulation after acute myocardial infarction

  2022cites this paper
• IL-39 increases ROS production and promotes the phosphorylation of p38 MAPK in the apoptotic cardiomyocytes.

  2021cites this paper
• Mendelian Randomization Studies in Stroke

  2021cites this paper
• The Entry and Egress of Monocytes in Atherosclerosis: A Biochemical and Biomechanical Driven Process

  2021cites this paper
• Immunotherapy and cardiovascular diseases (CVD): novel avenues for immunotherapeutic approaches.

  2021cites this paper
• Inflammation during Percutaneous Coronary Intervention—Prognostic Value, Mechanisms and Therapeutic Targets

  2021cites this paper
• Monocyte-Chemoattractant Protein-1 Levels in Human Atherosclerotic Lesions Associate With Plaque Vulnerability

  2021cites this paper
• Targeting inflammation in atherosclerosis — from experimental insights to the clinic

  2021cites this paper
• Post-ischemic Myocardial Inflammatory Response: A Complex and Dynamic Process Susceptible to Immunomodulatory Therapies

  2021cites this paper
• CCL2/CCR2 inhibition in atherosclerosis: a meta-analysis of preclinical studies

  2021influential citation
• Particulate Matter-Induced Acute Coronary Syndrome: MicroRNAs as Microregulators for Inflammatory Factors

  2021cites this paper
• The transcription factor interferon regulatory factor‐1 is an endogenous mediator of myocardial ischemia reperfusion injury

  2021cites this paper
• The effector cells and cellular mediators of immune system involved in cardiac inflammation and fibrosis after myocardial infarction

  2020cites this paper
• Targeting Chemokine—Glycosaminoglycan Interactions to Inhibit Inflammation

  2020influential citation
• Chemokines in Myocardial Infarction

  2020cites this paper
• Monocyte-chemoattractant protein-1 Levels in Human Atherosclerosis Associate with Plaque Vulnerability

  2020cites this paper
• The Regulatory Role of Histone Modification on Gene Expression in the Early Stage of Myocardial Infarction

  2020cites this paper
• Biomechanical assessment of remote and postinfarction scar remodeling following myocardial infarction

  2019cites this paper
• Tissue Resident CCR2− and CCR2+ Cardiac Macrophages Differentially Orchestrate Monocyte Recruitment and Fate Specification Following Myocardial Injury

  2019cites this paper
• Cardiac FGF23: new insights into the role and function of FGF23 after acute myocardial infarction.

  2019cites this paper
• G-Protein Coupled Receptor Targeting on Myeloid Cells in Atherosclerosis

  2019cites this paper
• Insights into the cardioprotective properties of n-3 PUFAs against ischemic heart disease via modulation of the innate immune system.

  2019cites this paper
• Genetically Determined Levels of Circulating Cytokines and Risk of Stroke: Role of Monocyte Chemoattractant Protein-1

  2019cites this paper
• DETERMINATION OF OPTIMAL PARAMETER ESTIMATES FOR MEDICAL INTERVENTIONS IN HUMAN METABOLISM AND INFLAMMATION

  2019cites this paper
• Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke: A Meta-Analysis of Population-Based Studies Involving 17,180 Individuals.

  2019cites this paper
• Heparin Binding Proteins as Therapeutic Target: An Historical Account and Current Trends

  2019cites this paper
• Immunotherapy for cardiovascular disease.

  2019cites this paper
• Monocytes Prime Autoreactive T cells After Myocardial Infarction.

  2019cites this paper
• MCP-1 mediates ischemia/reperfusion-induced cardiomyocyte apoptosis via MCPIP1 and CaSR.

  2019cites this paper
• Synthetic CpG oligonucleotides induce a genetic profile ameliorating murine myocardial I/R injury

  2018cites this paper
• PCSK9 induces a pro-inflammatory response in macrophages

  2018cites this paper
• Blocking CCL5-CXCL4 heteromerization preserves heart function after myocardial infarction by attenuating leukocyte recruitment and NETosis

  2018cites this paper
• Peroxisome proliferator-activated receptor-gamma targeting nanomedicine promotes cardiac healing after acute myocardial infarction by skewing monocyte/macrophage polarization in preclinical animal models

  2018cites this paper
• PCSK9 AND INFLAMMATION: IN VITRO STUDY ON HEPATOCYTES AND MACROPHAGES

  2018cites this paper
• Monocyte subtypes and the CCR2 chemokine receptor in cardiovascular disease.

  2017cites this paper
• Quantifying the area-at-risk of myocardial infarction in-vivo using arterial spin labeling cardiac magnetic resonance

  2017cites this paper
• MerTK Cleavage on Resident Cardiac Macrophages Compromises Repair After Myocardial Ischemia Reperfusion Injury

  2017cites this paper
• Monocyte subsets in myocardial infarction: A review.

  2017cites this paper
• Human Cardiac-Derived Stem/Progenitor Cells Fine-Tune Monocyte-Derived Descendants Activities toward Cardiac Repair

  2017cites this paper
• TITLE : Characterizing Myeloid Cell Activation in NF 1 Vasculopathy

  2017cites this paper
• Abrogation of CC chemokine receptor 9 ameliorates ventricular remodeling in mice after myocardial infarction

  2016cites this paper
• Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injury.

  2016cites this paper
• Inflammation and Inflammatory Cells in Myocardial Infarction and Reperfusion Injury: A Double-Edged Sword

  2016cites this paper
• Randomized Study of the Effects of Statin on Inflammatory and Prothrombotic States in Obese Adolescents

  2016cites this paper
• Nf1 +/ − monocytes/macrophages induce neointima formation via CCR2 activation

  2016cites this paper
• The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.

  2016cites this paper
• Inflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges.

  2016cites this paper
• Noninvasive Imaging of CCR2+ Cells in Ischemia‐Reperfusion Injury After Lung Transplantation

  2016cites this paper
• Interfering with the CCL2-glycosaminoglycan axis as a potential approach to modulate neuroinflammation.

  2016cites this paper
• Nf1+/- monocytes/macrophages induce neointima formation via CCR2 activation.

  2016cites this paper
• Targeting of CCL2-CCR2-Glycosaminoglycan Axis Using a CCL2 Decoy Protein Attenuates Metastasis through Inhibition of Tumor Cell Seeding1

  2016cites this paper
• Nanoparticle-Mediated Delivery of Irbesartan Induces Cardioprotection from Myocardial Ischemia-Reperfusion Injury by Antagonizing Monocyte-Mediated Inflammation

  2016cites this paper
• Progress in interventional cardiology: challenges for the future

  2015cites this paper
• Phylogeny and evolution of plant macrophage migration inhibitory factor/D-dopachrome tautomerase-like proteins

  2015cites this paper
• Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

  2015cites this paper
• The Positively Charged COOH-terminal Glycosaminoglycan-binding CXCL9(74–103) Peptide Inhibits CXCL8-induced Neutrophil Extravasation and Monosodium Urate Crystal-induced Gout in Mice*

  2015cites this paper
• The Damaging Interplay between Extracellular RNA and Tumor-Necrosis-Factor-α in Cardiac Ischemia/Reperfusion Injury: Prevention of Cardiomyocyte Death and Heart Failure by RNase1

  2015cites this paper
• Meeting report from the 2nd International Symposium on New Frontiers in Cardiovascular Research. Protecting the cardiovascular system from ischemia: between bench and bedside

  2015cites this paper
• Blockade of CCR3 retains the neutrophils, preserving their survival during healing after myocardial infarction

  2015cites this paper
• Atheroprotective role of C5ar2 deficiency in apolipoprotein E-deficient mice

  2015cites this paper
• Deficiency of MAPK-activated protein kinase 2 (MK2) prevents adverse remodelling and promotes endothelial healing after arterial injury

  2014cites this paper
• Effect of SDF-1 α on endogenous mobilized and transplanted stem cells in regeneration after myocardial infarction.

  2014cites this paper
• Targeting the chemokines in cardiac repair.

  2014cites this paper
• RNase1 prevents the damaging interplay between extracellular RNA and tumour necrosis factor-α in cardiac ischaemia/reperfusion injury

  2014cites this paper
• A Combinatorial Approach to Biophysically Characterise Chemokine-Glycan Binding Affinities for Drug Development

  2014cites this paper
• New targets for glycosaminoglycans and glycosaminoglycans as novel targets

  2013cites this paper
• Generation, function and therapeutic application of chemotactic cytokines in cardiovascular diseases

  2013cites this paper
• Antichemokine treatments in acute ischaemic c ardiovascular diseases

  2013cites this paper
• Anti-Inflammatory Strategies for Plaque Stabilization after Acute Coronary Syndromes

  2013cites this paper
• Regulation of Atherogenesis by Chemokines and Chemokine Receptors

  2013cites this paper
• Immunological aspects of atherosclerosis

  2013cites this paper
• Inflammation and Cerebral Aneurysms

  2013cites this paper
• Unique Transcriptional Profile of Sustained Ligand-Activated Preconditioning in Pre- and Post-Ischemic Myocardium

  2013cites this paper
• Compartmentalized Protective and Detrimental Effects of Endogenous Macrophage Migration-Inhibitory Factor Mediated by CXCR2 in a Mouse Model of Myocardial Ischemia/Reperfusion

  2013cites this paper